This analysis revealed notable differences in gene expression levels between control and bladder cancer groups, with significant genes including TP53, MET, PTEN, PIK3CA, CDH1, PALB2, KRAS, MSH2, MSH6, and MLH1 (Figure 7A). Here, MET is linked to urinary bladder cancer.